Literature DB >> 15451792

Left ventricular remodeling and heart failure in diabetic patients treated with primary angioplasty for acute myocardial infarction.

Nazario Carrabba1, Renato Valenti, Guido Parodi, Giovanni M Santoro, David Antoniucci.   

Abstract

BACKGROUND: Diabetes mellitus has been recognized as a strong predictor of heart failure (HF) in patients with acute myocardial infarction (AMI). However, considerable controversy exists regarding the pathogenetic mechanisms of HF after AMI in diabetic patients. We hypothesized that the increased incidence of HF in diabetic patients was associated with a greater propensity for left ventricular (LV) remodeling. METHODS AND
RESULTS: A series of 325 patients (42 diabetics) with AMI successfully treated with primary angioplasty underwent serial 2D echocardiography from admission to 1 and 6 months and 6-month angiography. No significant difference was found between diabetics and nondiabetics regarding baseline clinical, angiographic, and echocardiographic characteristics, as well as 6-month restenosis and reocclusion rates. At 6 months, a similar incidence of LV remodeling was observed in diabetics and nondiabetics (33% versus 25%; P=0.234), with similar patterns of changes in LV volumes and LV global and regional systolic function. At 5 years, the incidence of HF was higher in the diabetics (43% versus 20%, P=0.001). Diabetes was found to be an independent predictor of HF at 5 years (hazard ratio, 1.8; P=0.0366). However, LV remodeling was predictive of HF in the nondiabetics (P=0.023) but not in the diabetics (P=0.123). In a subgroup of patients, higher LV chamber stiffness (as assessed by echocardiography) was detected in the diabetics with HF.
CONCLUSIONS: The more frequent progression to HF in the diabetics after AMI is not explained by a greater propensity for LV remodeling. Other factors, such as diastolic dysfunction, may play a role.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15451792     DOI: 10.1161/01.CIR.0000143376.64970.4A

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  18 in total

Review 1.  The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities.

Authors:  Nikolaos G Frangogiannis
Journal:  J Cardiovasc Pharmacol       Date:  2014-03       Impact factor: 3.105

2.  Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model.

Authors:  Kazuhisa Kondo; Rei Shibata; Kazumasa Unno; Masayuki Shimano; Masakazu Ishii; Tetsutaro Kito; Satoshi Shintani; Kenneth Walsh; Noriyuki Ouchi; Toyoaki Murohara
Journal:  Circ Cardiovasc Interv       Date:  2010-03-23       Impact factor: 6.546

3.  CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism.

Authors:  Takahiro Kambara; Koji Ohashi; Rei Shibata; Yasuhiro Ogura; Sonomi Maruyama; Takashi Enomoto; Yusuke Uemura; Yuuki Shimizu; Daisuke Yuasa; Kazuhiro Matsuo; Megumi Miyabe; Yoshiyuki Kataoka; Toyoaki Murohara; Noriyuki Ouchi
Journal:  J Biol Chem       Date:  2012-04-18       Impact factor: 5.157

Review 4.  Diabetes and heart failure in the post-myocardial infarction patient.

Authors:  Jerry D Estep; David Aguilar
Journal:  Curr Heart Fail Rep       Date:  2006-12

Review 5.  The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.

Authors:  Sumanth D Prabhu; Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2016-06-24       Impact factor: 17.367

Review 6.  Targeting inflammatory pathways in myocardial infarction.

Authors:  Panagiota Christia; Nikolaos G Frangogiannis
Journal:  Eur J Clin Invest       Date:  2013-06-17       Impact factor: 4.686

Review 7.  The inflammatory response in myocardial injury, repair, and remodelling.

Authors:  Nikolaos G Frangogiannis
Journal:  Nat Rev Cardiol       Date:  2014-03-25       Impact factor: 32.419

Review 8.  Diabetic cardiomyopathy: pathophysiology and clinical features.

Authors:  Takayuki Miki; Satoshi Yuda; Hidemichi Kouzu; Tetsuji Miura
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

Review 9.  Impact of diabetes on postinfarction heart failure and left ventricular remodeling.

Authors:  Helene von Bibra; Martin St John Sutton
Journal:  Curr Heart Fail Rep       Date:  2011-12

10.  Evaluation of the effect of elective percutaneous coronary intervention as a treatment method on the left ventricular diastolic dysfunction in patients with coronary artery disease.

Authors:  Seyed Reza Hashemi; Mohammadreza Motamedi; Mohammad Khani; Manouchehr Hekmat; Latif Gachkar; Atieh Rezaeefar
Journal:  J Tehran Heart Cent       Date:  2010-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.